Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

March 21, 2012

Low COST Vitamin D vs. High Costs medications

  • An MS Patients Story
    /
  • Vitamins and Supplements
    /
Henry provided me with the following links for you to decipher, which he wrote: http://www.vitamindwiki.com/tiki-view_blog_post.php?postId=76    vitamin D vs drug http://www.vitamindwiki.com/tiki-view_blog_post.php?postId=62   …
An MS Patients Story

March 21, 2012

STRATIFY JCV is a blood test that detects anti-JC virus (JCV) antibodies to help assess the risk of PML in patients with MS

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
  • Tysabri
    /
If you are unable to read the HTML email below, please view it online. Visit STRATIFYJCV.com/US to watch an educational…
MS Drug Therapies

March 17, 2012

UK MS News Update: Cost body backs Novartis MS pill in about-turn

  • MS Drug Therapies
    /
LONDON (Reuters) – Novartis’s multiple sclerosis pill Gilenya, one of its top new drug hopes, has been recommended for use…
MS Drug Therapies

March 16, 2012

Back on Track: Phase III Study of Teva’s Oral Laquinimod Published in the New England Journal of Medicine Demonstrates Clinical Benefits for Multiple Sclerosis Patients

  • MS Drug Therapies
    /
  • Oral MS Medications
    /
March 15, 2012 Phase III ALLEGRO study results showed laquinimod reduced the annual rate of relapses, slowed the progression of…
MS Drug Therapies

March 16, 2012

NICE: fingolimod gets the thumbs up in the UK

  • MS Drug Therapies
    /
In its final draft guidance, out today (16 March), NICE, has recommended fingolimod, to help reduce the number of relapses for…
MS Drug Therapies

March 16, 2012

Myelin Repair Foundation appointed Dr. Alfred Sandrock, Chief Medical Officer from Biogen Idec to our Clinical Advisory Board

  • Misc. MS Related
    /
  We are very pleased to announce that this week the Myelin Repair Foundation appointed Dr. Alfred Sandrock, Chief Medical Officer…
Misc. MS Related

March 16, 2012

Though scientists haven’t figured out a way to prevent MS, there are some things you may be able to do to reduce your risk

  • MS Research Study and Reports
    /
By Connie Brichford Medically reviewed by Cynthia Haines, MD   More than 400,000 people in the United States have multiple sclerosis, and someone…
MS Research Study and Reports

March 16, 2012

Diet as a Risk Factor for MS: The Evidence

  • Multiple Sclerosis
    /
  • Nutrition
    /
  • Vitamins and Supplements
    /
By Connie Brichford Medically reviewed by Cynthia Haines, MD   Doctors and other health-care professionals recommend a healthy diet to all their patients, and…
Multiple Sclerosis

March 16, 2012

MAKScientific, a company focused on therapeutics that modulate cannabinoid pathways, entered into an exclusive, worldwide option and collaboration agreement with Biogen Idec

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
MAKScientific, a company focused on therapeutics that modulate cannabinoid pathways, entered into an exclusive, worldwide option and collaboration agreement with Biogen…
MS Drug Therapies

March 15, 2012

A Nat’l MS Society webcast on : Research in Understanding & Treating Progressive Multiple Sclerosis

  • MS Research Study and Reports
    /
The National MS Society and MS Learn Online invite you to view..        Working for Me: Research in Understanding &…
MS Research Study and Reports

Categories

Latest Blog Posts